VIDEO: Non-invasive PCC test offers high negative predictive value for prostate cancer
In this video Andres Correa, MD, discusses the MiR Sentinel PCC4 test, which has been shown to offer a high predictive value when testing for prostate cancer.
"The most important factor is the high negative predictive factor that they reported. This means that if the test is negative, you can feel very confident that the patient does not need a prostate biopsy," Correa, assistant professor in the department of surgery in the urologic oncology division at Fox Chase Cancer Center in Philadelphia.
In addition, the test is non-invasive and may not require the patient to undergo an MRI or visit a clinician’s office.
"With the pandemic this [test] is something that can potentially be done at home," Correa said.
Collapse
Klotz L, et al. Abstract LBA02. Presented at AUA Annual Meeting; September 10-12, 2021 (virtual meeting).
Read more about